This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Asia
October 21 - 23, 2024
Presented in Japan Standard Time

The Westin Miyako Kyoto
Delivered as a Hybrid Event

Menu
BOOK NOW
get_app

DOWNLOAD THE PRELIMINARY ANTIBODY ENGINEERING & THERAPEUTICS ASIA 2024 AGENDA

  • Bispecific and Multispecific Antibodies
  • Antibodies for Novel/Challenging Targets
  • Immune Cell Engager Antibody Technologies
  • Antibody-Drug Conjugates
  • Disease-Area Specific Antibodies
  • AI/Machine Learning for Antibody Developability
  • New Binders, Therapeutic Modalities & Antibody Formats
  • Agonist Antibodies and Conditional Antibodies
  • Novel Antibody Technologies and Applications
  • Preclinical and Clinical Antibody Case Studies

Log in or Create an Informa Connect Account to Access this content

Creating an account also means you'll get special access to event updates and exclusive industry content.